Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 7.25 INR
Change Today +0.30 / 4.32%
Volume 765.0
ADVL On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

advik laboratories ltd (ADVL) Snapshot

Open
7.25
Previous Close
6.95
Day High
7.25
Day Low
7.25
52 Week High
10/23/14 - 10.97
52 Week Low
05/5/14 - 3.65
Market Cap
108.9M
Average Volume 10 Days
1.5K
EPS TTM
0.53
Shares Outstanding
15.0M
EX-Date
--
P/E TM
13.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for ADVIK LABORATORIES LTD (ADVL)

Related News

No related news articles were found.

advik laboratories ltd (ADVL) Related Businessweek News

No Related Businessweek News Found

advik laboratories ltd (ADVL) Details

Advik Laboratories Limited manufactures and sells pharmaceutical products primarily in India. The company offers ethical and generic products. Its generic products include antibacterials, antiallergics, antifungals, anthelminthics, antihypertensives, antimalarials, antituberculosis, corticosteroids, erectile dysfunction, gastrointestinal agents, and sedatives, as well as analgesic, antipyretic, and anti-inflammatory. The company’s ethical products comprise Wibatol, Robial, Twosum, Majispa, Stibomin, and Chewfe-C tablets, as well as Arfa gel. It also exports its products to countries in the Middle East, South America, and Africa. Advik Laboratories Limited was incorporated in 1994 and is based in New Delhi, India.

Founded in 1994

advik laboratories ltd (ADVL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

advik laboratories ltd (ADVL) Key Developments

Advik Laboratories Ltd. Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Advik Laboratories Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales of INR 28.014 million compared to INR 84.166 million a year ago. Profit from operations before other income finance costs and exceptional items was INR 3.501 million compared to INR 4.629 million a year ago. Profit from ordinary activities before tax was INR 0.384 million compared to INR 2.290 million a year ago. Profit from ordinary activities after tax was INR 0.269 million compared to INR 1.582 million a year ago. Diluted earnings per share were INR 0.014 compared to INR 0.150 a year ago. For the year, the company reported net sales of INR 102.341 million compared to INR 191.345 million a year ago. Profit from operations before other income finance costs and exceptional items was INR 9.738 million compared to INR 11.590 million a year ago. Profit from ordinary activities before tax was INR 0.814 million compared to INR 2.795 million a year ago. Profit from ordinary activities after tax was INR 0.570 million compared to INR 1.931 million a year ago. Diluted earnings per share were INR 0.037 compared to INR 0.200 a year ago.

Advik Laboratories Ltd., Board Meeting, Feb 13, 2015

Advik Laboratories Ltd., Board Meeting, Feb 13, 2015. Agenda: To consider quarterly results.

Advik Laboratories Ltd. Announces Executive Changes

Advik Laboratories Ltd. announced that the Board of Directors of the company at its meeting held on December 08, 2014, has considered and approved the resignation of Ms. Anjali Kalra as the Company Secretary of the company and appointed Ms. Vaishali Anand as the Company Secretary of the company with effect from December 08, 2014 and designated her as the KMP & Compliance Officer of the company as per the provisions of Section 203 of the Companies Act, 2013 & the Listing Agreement.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ADVL:IN 7.25 INR +0.30

ADVL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ADVL.
View Industry Companies
 

Industry Analysis

ADVL

Industry Average

Valuation ADVL Industry Range
Price/Earnings 41.4x
Price/Sales 0.5x
Price/Book 0.5x
Price/Cash Flow 8.7x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADVIK LABORATORIES LTD, please visit www.advikindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.